3. GOOD HEALTH AND WELL-BEING

Truist Financial Corp Has $19.17 Million Stock Holdings in Encompass Health Co. (NYSE:EHC) – Defense World

Written by Amanda

Truist Financial Corp Has $19.17 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)  Defense World

Truist Financial Corp trimmed its holdings in Encompass Health Co. (NYSE:EHCGet Rating) by 5.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 269,527 shares of the company’s stock after selling 16,865 shares during the quarter. Truist Financial Corp’s holdings in Encompass Health were worth $19,166,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in the company. Louisiana State Employees Retirement System lifted its stake in shares of Encompass Health by 2.0% in the 1st quarter. Louisiana State Employees Retirement System now owns 26,100 shares of the company’s stock valued at $1,904,000 after purchasing an additional 500 shares during the period. Hotaling Investment Management LLC acquired a new position in shares of Encompass Health in the 1st quarter valued at about $201,000. Strs Ohio lifted its stake in shares of Encompass Health by 90.3% in the 1st quarter. Strs Ohio now owns 98,200 shares of the company’s stock valued at $6,983,000 after purchasing an additional 46,600 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Encompass Health by 13.4% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 270,164 shares of the company’s stock valued at $19,211,000 after purchasing an additional 31,937 shares during the period. Finally, Virginia Retirement Systems ET AL lifted its stake in shares of Encompass Health by 28.9% in the 1st quarter. Virginia Retirement Systems ET AL now owns 19,600 shares of the company’s stock valued at $1,394,000 after purchasing an additional 4,400 shares during the period. 91.70% of the stock is currently owned by institutional investors.

A number of analysts recently commented on the company. Raymond James decreased their target price on Encompass Health from $85.00 to $70.00 in a research report on Friday, June 17th. Stephens decreased their target price on Encompass Health from $78.00 to $74.00 and set an “overweight” rating for the company in a research report on Tuesday, June 21st. Royal Bank of Canada decreased their target price on Encompass Health from $85.00 to $82.00 in a research report on Wednesday, June 8th. Truist Financial decreased their target price on Encompass Health from $85.00 to $75.00 and set a “buy” rating for the company in a research report on Tuesday, June 21st. Finally, Credit Suisse Group decreased their target price on Encompass Health from $83.00 to $82.00 and set an “outperform” rating for the company in a research report on Friday, June 10th. Nine investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $79.56.

Shares of EHC opened at $48.41 on Friday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 1.26 and a current ratio of 1.26. The stock has a 50 day moving average price of $59.90 and a two-hundred day moving average price of $64.45. The firm has a market capitalization of $4.83 billion, a P/E ratio of 12.38, a P/E/G ratio of 1.75 and a beta of 1.00. Encompass Health Co. has a 52 week low of $44.33 and a 52 week high of $85.75.

Encompass Health (NYSE:EHCGet Rating) last issued its quarterly earnings data on Wednesday, April 27th. The company reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.32 billion. Encompass Health had a return on equity of 17.99% and a net margin of 7.51%. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.05 EPS. On average, equities analysts forecast that Encompass Health Co. will post 3.78 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 20th. Stockholders of record on Wednesday, July 13th will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend is Tuesday, July 12th. Encompass Health’s dividend payout ratio is presently 28.64%.

In other Encompass Health news, Director Kevin J. O’connor bought 1,000 shares of Encompass Health stock in a transaction dated Friday, May 6th. The stock was bought at an average cost of $66.48 per share, with a total value of $66,480.00. Following the completion of the acquisition, the director now directly owns 3,436 shares in the company, valued at approximately $228,425.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.70% of the company’s stock.

About Encompass Health (Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Further Reading

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCGet Rating).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Encompass Health and related companies with MarketBeat.com’s FREE daily email newsletter.

Source: defenseworld.net

About the author

Amanda

Hi there, I am Amanda and I work as an editor at impactinvesting.ai;  if you are interested in my services, please reach me at amanda.impactinvesting.ai

Leave a Comment